Call for Proposals: ADDF and the AFTD Invite Scientists to Apply for FTD Biomarker Grants

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia-specified biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.

More information regarding the Call is attached, and may also be found at

Resize text-+=